相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis
C. Mao et al.
ANNALS OF ONCOLOGY (2012)
Mutations and epimutations in the origin of cancer
Paivi Peltomaki
EXPERIMENTAL CELL RESEARCH (2012)
Alterations in PTEN and PIK3CA in colorectal cancers in the EPIC Norfolk study: associations with clinicopathological and dietary factors
Adam Naguib et al.
BMC CANCER (2011)
BRAF V600E mutation and resistance to anti-EGFR monoclonal antibodies in patients with metastatic colorectal cancer: a meta-analysis
Chen Mao et al.
MOLECULAR BIOLOGY REPORTS (2011)
PIK3CA Mutations Frequently Coexist with RAS and BRAF Mutations in Patients with Advanced Cancers
Filip Janku et al.
PLOS ONE (2011)
Prevalence and Heterogeneity of KRAS, BRAF, and PIK3CA Mutations in Primary Colorectal Adenocarcinomas and Their Corresponding Metastases
Stephan E. Baldus et al.
CLINICAL CANCER RESEARCH (2010)
Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab
Javier Rodriguez et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2010)
Predictive and prognostic value of KRAS mutations in metastatic colorectal cancer patients treated with cetuximab: A meta-analysis of 22 studies
Li-Xin Qiu et al.
EUROPEAN JOURNAL OF CANCER (2010)
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Alberto Bardelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
Arnaud D. Roth et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
Wendy De Roock et al.
LANCET ONCOLOGY (2010)
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy
Milena Casula et al.
BMC CANCER (2009)
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population
Grazia Palomba et al.
BMC CANCER (2009)
Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR
Volker Heinemann et al.
CANCER TREATMENT REVIEWS (2009)
Distinct BRAF (V600E) and KRAS Mutations in High Microsatellite Instability Sporadic Colorectal Cancer in African Americans
Krishan Kumar et al.
CLINICAL CANCER RESEARCH (2009)
BRAF Mutation in Metastatic Colorectal Cancer.
Jolien Tol et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Assessment of somatic k-RAS mutations as a mechanism associated with resistance to EGFR-targeted agents:: a systematic review and meta-analysis of studies in advanced non-small-cell lung cancer and metastatic colorectal cancer
Helena Linardou et al.
LANCET ONCOLOGY (2008)
Oncogenic activation of the RAS/RAF signaling pathway impairs the response of metastatic colorectal cancers to anti-epidermal growth factor receptor antibody therapies
Silvia Benvenuti et al.
CANCER RESEARCH (2007)
BRAF mutation, CpG island methylator phenotype and microsatellite instability occur more frequently and concordantly in mucinous than non-mucinous colorectal cancer
H Tanaka et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies
S Service et al.
NATURE GENETICS (2006)
Spectrum and prevalence of BRCA1 and BRCA2 germline mutations in Sardinian patients with breast carcinoma through hospital-based screening
G Palomba et al.
CANCER (2005)
BRAF mutations in colorectal carcinoma suggest two entities of microsatellite-unstable tumors
N Lubomierski et al.
CANCER (2005)
Poor survival associated with the BRAF V600E mutation in microsatellite-stable colon cancers
WS Samowitz et al.
CANCER RESEARCH (2005)
Mutant PIK3CA promotes cell growth and invasion of human cancer cells
Y Samuels et al.
CANCER CELL (2005)
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting of MLH1 and MSH2 inactivation in familial cases
M Colombino et al.
ANNALS OF ONCOLOGY (2003)
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma
M Colombino et al.
ANNALS OF ONCOLOGY (2002)
Tumorigenesis -: RAF/RAS oncogenes and mismatch-repair status
H Rajagopalan et al.
NATURE (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
分享论文
